Industry – Talk Bio

Are the Good Times in Biotech Back? – Insights from Post-Hoc Live’s 2025 Industry Sentiment

3 weeks ago talkbio0Tagged Aggressive Periodontitis, delays, executive survey, Funding, Industry, M&A, Post-Hoc Live, public biotech, Sentiment, United States Food and Drug Administration

biotech sentiment; Post-Hoc Live; 2025 industry outlook; biotech M&A; FDA delays; executive survey; public biotech companies; JP Morgan effect; biotech funding

UK Proposes Raising Payment Scheme for Branded Medicines to Nearly 25% Amid Industry Pushback

3 weeks ago talkbio0Tagged Consultation, drugmakers, Industry, Nance-Horan syndrome, payment, pharmaceutical rebates, Pricing, Response process, spending, statutory scheme, UK

UK medicine pricing; NHS spending; statutory scheme; drugmakers; payment percentage; pharmaceutical rebates; industry response; consultation 2025

Endpoints News Launches Industry Sentiment Survey, But No Evidence Yet of a New Biopharma Sentiment Index

4 weeks ago talkbio0Tagged Biopharma, Endpoints, Industry, John Carroll, News [Publication Type], Sentiment, Surveys, trends qualifier

Endpoints News; biopharma; sentiment; survey; industry trends; John Carroll

Meeting on the Mesa 2025 Arrives Amid Mixed Signals for Cell and Gene Therapy Sector

4 weeks ago talkbio0Tagged Advanced therapies, Alternative, Cells, Clinical Trials, commercialization, Gene Modification, gene therapy, Industry, meeting, MESA, partnerships, payment, Phoenix Arizona, regulatory challenges, RNA, Messenger, Study models

Cell and gene therapy; Meeting on the Mesa; Commercialization; Clinical trials; Advanced therapies; Industry partnerships; Regulatory challenges; Phoenix Arizona; mRNA; Gene editing; Alternative payment models

Takeda to Cut 137 Staffers After Exiting Cell Therapy Research

1 month ago talkbio0Tagged Cell Therapy, Exit, Industry, layoffs, Massachusetts (geographic location), pipeline shake-up, portfolio reprioritization, R&D, restructuring, strategic, Takeda

Takeda; layoffs; cell therapy exit; biotech industry; restructuring; Massachusetts R&D; strategic portfolio reprioritization; pipeline shake-up

Endpoints News to Announce 2025 ‘Endpoints 11’ Biotechs to Watch Live in Boston

2 months ago talkbio0Tagged Biopharma, biotech startups, City of Boston, Endpoints, Industry, innovation, live event, trends qualifier

Endpoints 11; biotech startups; biopharma; Boston; live event; industry trends; biotech innovation

How Past Endpoints 11 Winners Fared During the 2025 Biotech Downturn

2 months ago talkbio0Tagged 2025, biotech downturn, Endpoints, Industry, trends qualifier, winners

Endpoints 11; biotech downturn 2025; biotech winners; Xaira Therapeutics; biotech awards; industry trends

Endpoints 11: Biopharma’s most promising startups revealed live in Boston this September

3 months ago talkbio0Tagged Aves, Biopharma, biotech startups, biotechs, Boston event, Endpoints, GALA peptide, Industry, Rating (action), real-time, State Room

Endpoints 11; biotech startups; biopharma; Boston event; State Room; awards gala; early bird rate; industry insiders; 2025 most promising biotechs; real-time reveal